Image commercially licensed from: Unsplash
Living with inflammatory bowel disease (IBD), ulcerative colitis, or Crohn’s disease can be challenging due to the unpredictable nature of symptoms impacting both physical and mental well-being. Fluctuating conditions severely affect daily life, hindering regular activities and causing emotional distress.
Access to proper healthcare remains an issue, especially in low- and middle-income countries, leading to delays in diagnosis and suboptimal treatments. Developed countries offer more options for specialized care, innovative treatments, and support services. Improved global healthcare accessibility is crucial in reducing the burden of these conditions.
Central to this movement is Evinature, a startup that leads cutting-edge research in integrative therapies for IBD. Evinature was founded on the nexus of two medical philosophies. By bridging the gap between modern and traditional medicine, the company aims to provide more patients with safe and natural remedies that are embraced by the medical community.
The company firmly believes that it’s time for healthcare to prioritize patient global accessibility to accurate medical assessments and affordable treatments. Evinature operates without seeking patents, following trends, or spreading misinformation. Their approach involves the careful development, testing, and verification of remedies before giving back to the community. Transparency and integrity are at the core of their mission.
Just recently, the team at Evinature further solidified the role of Curcumin-QingDai as a promising combination to combat IBD in a randomized, double-blinded, placebo-controlled trial.
The study was divided into 2 parts. In Part I of the study, they tested CurQD on patients with active UC, which was determined by scores on the Colitis Activity Index and endoscopic subscore. In Part II, they conducted a placebo-controlled trial in Israel and Greece, where active UC patients were randomly assigned to either take CurQD 3 g/d or a placebo for 8 weeks at a ratio of 2:1.
They measured the response based on certain criteria, like improvement in the UC score and reduction in fecal calprotectin. Patients who responded well continued taking either curcumin or placebo alone for another 8 weeks. They also looked at the activation of a certain pathway in the patients.
The results? In Part I, 7 out of 10 patients responded to CurQD, and 3 out of 10 achieved clinical remission. In Part II, 43% of CurQD patients achieved the desired outcome at week 8 compared to only 8% of placebo patients. CurQD patients showed a better response in terms of clinical improvement, remission, and endoscopic improvement compared to the placebo group. By week 16, the response rate was still high for patients continuing with curcumin.
Why is the CurQD Protocol a Game Changer?
The CurQD® Protocol is a collection of natural and clinically proven regimens, meticulously tailored to address each stage of the condition in a highly individualized manner. Evinature has now simplified the process, allowing individuals to benefit from the comfort of their own homes.
Prospective users can take advantage of the free online assessment offered by Evinature to discover the most effective protocol for their specific needs. The company diligently tracks the progress of each individual and guides them through every stage with regular follow-ups and full clinic support.
Each 6-week protocol consists of a carefully selected set of three products that align with the individual’s current condition, based on insights from clinical trials. The free online assessment, meticulously developed by leading GI researchers and gastroenterologists, relies on validated disease indexes to ensure precision and effectiveness in delivering a tailored solution.
To further enhance the efficacy of the treatment, Evinature conducts free online follow-up assessments, allowing for necessary adjustments to the protocol along the way, leading to the best possible long-term outcomes. Regular follow-ups play a vital role in the CurQD® Protocol, with the company’s team of experts providing unwavering support to users at every step of their journey. The primary objective is to optimize the benefits of the protocol, with constant check-ins and adjustments made based on the individual’s response.
